2 employees
Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication.
2011
$11M
from 2 investors over 2 rounds
Gemphire Therapeutics raised undisclosed on January 1, 2020
Investors: Excel Venture Management, LLC
Gemphire Therapeutics raised $11M on April 27, 2016
Investors: Grand Angels